Early Evolution of Hepatitis C Virus (HCV) Quasispecies after Liver Transplant for HCV‐Related Disease
Author(s) -
Évelyne Schvoerer,
Eric Soulier,
Cathy Royer,
Anne-Catherine Renaudin,
Christine Thumann,
Samira FafiKremer,
Nicolas Brig,
Stéphane Doridot,
Nicolás Meyer,
Patricia RecordonPinson,
Bernard Ellero,
MarieLorraine WoehlJaegle,
Carole Meyer,
Philippe Wolf,
Pierre Zachary,
Thomas F. Baumert,
Françoise StollKeller
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/519691
Subject(s) - viral quasispecies , hypervariable region , hepatitis c virus , hepatocellular carcinoma , virology , biology , liver disease , virus , genotype , hepacivirus , viral disease , immunology , gene , genetics , antibody , biochemistry
End-stage liver disease as a result of chronic hepatitis C virus (HCV) infection is the main indication for liver transplant (LT), but allografts are systematically infected with HCV soon after transplant. Viral quasispecies are poorly described during the early posttransplant period.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom